Author

M. Sculco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Hariharan· 1 shared B. Vrugt· 1 shared C. Blanquart· 1 shared C. Meiller· 1 shared D. JEAN· 1 shared E. Felley-Bosco· 1 shared H. Rehrauer· 1 shared I. Opitz· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hariharan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Heterogeneity of RNA editing in mesothelioma and how RNA editing enzyme ADAR2 affects mesothelioma cell growth, response to chemotherapy and tumor microenvironment

A. Hariharan, W. Qi, H. Rehrauer, L. Wu, M. Ronner, M. Wipplinger, J. Kresoja-Rakic, S. Sun, L. Oton-Gonzales, M. Sculco, V. Serre-Beinier, C. Meiller, C. Blanquart, J.-F. Fonteneau, B. Vrugt, , E. Felley-Bosco

This study examines RNA editing heterogeneity in mesothelioma and shows ADAR2's role in cell growth, chemotherapy response, and tumor microenvironment regulation.

bioRxiv · Jul 12, 2022Cancer Biology